William R. Welch

17.0k total citations · 4 hit papers
149 papers, 13.6k citations indexed

About

William R. Welch is a scholar working on Reproductive Medicine, Molecular Biology and Surgery. According to data from OpenAlex, William R. Welch has authored 149 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Reproductive Medicine, 44 papers in Molecular Biology and 28 papers in Surgery. Recurrent topics in William R. Welch's work include Ovarian cancer diagnosis and treatment (54 papers), Endometriosis Research and Treatment (13 papers) and RNA modifications and cancer (11 papers). William R. Welch is often cited by papers focused on Ovarian cancer diagnosis and treatment (54 papers), Endometriosis Research and Treatment (13 papers) and RNA modifications and cancer (11 papers). William R. Welch collaborates with scholars based in United States, Australia and Hong Kong. William R. Welch's co-authors include Noel Weidner, Judah Folkman, Joseph P. Semple, Daniel W. Cramer, Samuel C. Mok, Robert E. Scully, Ross S. Berkowitz, Robert C. Knapp, Robert C. Bast and Salim E. Kabawat and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

William R. Welch

149 papers receiving 13.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 4.9k citations William R. Welch et al. profile →
Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125

1983 485 citations William R. Welch, Robert C. Knapp et al. profile →
Determinants of Ovarian Cancer Risk. II. Inferences Regarding Pathogenesis<xref ref-type="fn" rid="FN2">2</xref>

1983 433 citations Daniel W. Cramer, William R. Welch profile →
Effect of Asphaltene Structure on Association and Aggregation Using Molecular Dynamics

2013 296 citations William R. Welch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William R. Welch United States	53	5.3k	3.9k	3.1k	2.9k	1.8k	149	13.6k
Christian Marth Austria	61	5.8k 1.1×	3.1k 0.8×	5.3k 1.7×	2.8k 1.0×	1.6k 0.9×	411	14.0k
Gordon C. Jayson United Kingdom	56	4.7k 0.9×	4.1k 1.1×	4.1k 1.3×	2.1k 0.7×	2.2k 1.2×	257	14.0k
Rainer Kimmig Germany	52	2.2k 0.4×	3.6k 0.9×	3.6k 1.2×	2.3k 0.8×	1.5k 0.9×	402	10.3k
Gunnar B. Kristensen Norway	59	3.6k 0.7×	7.6k 2.0×	4.3k 1.4×	2.2k 0.8×	3.8k 2.1×	266	14.7k
Ib Jarle Christensen Denmark	61	5.4k 1.0×	1.3k 0.3×	5.6k 1.8×	4.0k 1.4×	1.9k 1.1×	446	15.3k
Andrew Berchuck United States	73	8.1k 1.5×	6.9k 1.8×	5.8k 1.9×	3.8k 1.3×	1.6k 0.9×	358	19.9k
C. Blake Gilks Canada	75	4.6k 0.9×	7.2k 1.9×	4.6k 1.5×	3.0k 1.0×	1.9k 1.1×	291	16.7k
Anaís Malpica United States	64	2.4k 0.5×	5.4k 1.4×	2.3k 0.7×	1.1k 0.4×	2.3k 1.3×	281	13.0k
Rex C. Bentley United States	49	2.7k 0.5×	1.6k 0.4×	1.6k 0.5×	1.2k 0.4×	1.8k 1.0×	163	8.5k
Robert L. Coleman United States	72	7.7k 1.5×	9.5k 2.4×	7.7k 2.5×	3.5k 1.2×	4.1k 2.3×	690	23.3k

Countries citing papers authored by William R. Welch

Since Specialization

Citations

This map shows the geographic impact of William R. Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Welch more than expected).

Fields of papers citing papers by William R. Welch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Welch. The network helps show where William R. Welch may publish in the future.

Co-authorship network of co-authors of William R. Welch

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Welch. A scholar is included among the top collaborators of William R. Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Welch. William R. Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Junzheng, Shu‐Kay Ng, Kuan‐Chun Huang, et al.. (2017). Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube. BMC Cancer. 17(1). 422–422. 11 indexed citations

Huang, Kuan‐Chun, Junzheng Yang, Shu‐Kay Ng, et al.. (2016). Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells. European Journal of Cancer. 67. 152–163. 34 indexed citations

Yang, Junzheng, Shu‐Kay Ng, Shubai Liu, et al.. (2012). Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures. BMC Cancer. 12(1). 329–329. 54 indexed citations

Gao, Zhijian, Xiaoyin Xu, Bruce A. McClane, et al.. (2010). C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin. Clinical Cancer Research. 17(5). 1065–1074. 43 indexed citations

Garner, Elizabeth, et al.. (2007). Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecologic Oncology. 106(2). 311–317. 55 indexed citations

Welch, William R., et al.. (2007). Stratifin expression in epithelial ovarian cancer: the role of methylation in vitro and in vivo. Cancer Research. 67. 1057–1057. 1 indexed citations

Terry, Kathryn L., Linda Titus‐Ernstoff, John McKolanis, et al.. (2007). Incessant Ovulation, Mucin 1 Immunity, and Risk for Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 16(1). 30–35. 52 indexed citations

Wamunyokoli, Fred, Tomás Bonome, Colleen M. Feltmate, et al.. (2006). Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance. Clinical Cancer Research. 12(3). 690–700. 50 indexed citations

Drapkin, Ronny, Hans Henning von Horsten, Yafang Lin, et al.. (2005). Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas. Cancer Research. 65(6). 2162–2169. 457 indexed citations

10.

Feltmate, Colleen M., Kenneth R. Lee, Michael E. Johnson, et al.. (2005). Whole-Genome Allelotyping Identified Distinct Loss-of-Heterozygosity Patterns in Mucinous Ovarian and Appendiceal Carcinomas. Clinical Cancer Research. 11(21). 7651–7657. 17 indexed citations

11.

Wang, Vivian, Cheng Li, Ming Gang Lin, et al.. (2005). Ovarian cancer is a heterogeneous disease. Cancer Genetics and Cytogenetics. 161(2). 170–173. 37 indexed citations

12.

Lu, K. H., J. E. Garber, D. W. Cramer, et al.. (1999). Prophylactic oophorectomies in women at high risk for ovarian cancer. Gynecologic Oncology. 72(3). 450–451. 2 indexed citations

13.

Poteat, Harry T., G.T.S. Ho, Mei‐Ling Ting Lee, et al.. (1997). The Utility of Patient Age in Evaluating Prostate Cancer. American Journal of Clinical Pathology. 107(3). 337–344. 5 indexed citations

14.

Muto, Michael G., Daniel W. Cramer, Douglas L. Brown, et al.. (1993). Screening for Ovarian Cancer: The Preliminary Experience of a Familial Ovarian Cancer Center. Gynecologic Oncology. 51(1). 12–20. 53 indexed citations

15.

Harlow, Bernard L., et al.. (1991). The Influence of Lactose Consumption on the Association of Oral Contraceptive Use and Ovarian Cancer Risk. American Journal of Epidemiology. 134(5). 445–453. 19 indexed citations

16.

Hill, Joseph A., et al.. (1990). Induction of class II major histocompatibility complex antigen expression in human granulosa cells by interferon gamma: A potential mechanism contributing to autoimmune ovarian failure. American Journal of Obstetrics and Gynecology. 162(2). 534–540. 53 indexed citations

17.

Jenison, Eric L., Anthony Montag, C. Thomas Griffiths, et al.. (1989). Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma. Gynecologic Oncology. 32(1). 65–71. 126 indexed citations

18.

Welch, William R., Yao Fu, Stanley J. Robboy, & Arthur L. Herbst. (1983). Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. Gynecologic Oncology. 15(2). 230–238. 11 indexed citations

19.

Cramer, Daniel W., et al.. (1983). Mumps, menarche, menopause, and ovarian cancer. American Journal of Obstetrics and Gynecology. 147(1). 1–6. 41 indexed citations

20.

Cramer, Daniel W., et al.. (1982). Ovarian cancer and talc. A case-control study. Cancer. 50(2). 372–376. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact